Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Avalon Portfolio, Llc
Avalon Portfolio Nominates Slate of Directors for TomoTherapy Board
January 16th, 2009
Avalon Portfolio, LLC, the investment arm of Avalon Capital Group, announced that on December 23, 2008 it nominated four new directors to serve on the board of TomoTherapy Inc. (NASDAQ:TOMO). This step is the latest move by the investment firm to generate greater value for the company's shareholders in the wake of the precipitous fall in TomoTherapy's stock price since 2007. The company has lost some 85% of its value year-to-date, with most of the decline occurring prior to the meltdown of the financial markets this fall. Avalon's nominees are committed to having the company's board explore all strategic options to maximize shareholder value. "Unless new management and...
Source: Health Business Week (2009-01-16)
|
